Peptide Claim Checker

Pick a peptide and a popular claim about it. The tool returns the evidence grade, whether human evidence exists, the UK regulatory concern, and safer wording you could use instead. Powered by our public evidence grading methodology.

Peptide

Claim

ACE-031 — “Available from research suppliers for muscle building”

Discontinued investigational compound. Acceleron Pharma stopped development of ACE-031 in 2013 after safety signals. Not a licensed UK medicine; not currently in active clinical development. Prohibited under WADA S1.2 / S4.

Evidence level: ETheoretical / insufficient
Human evidence?: No
Regulatory concern: High

Safer wording

Development was halted on safety grounds. Any 'ACE-031' from grey-market suppliers has no provenance verification.

Full profile: /peptides/ace-031

This tool covers peptides that have passed editorial review with structured claim-vs-evidence data (71 so far). More peptides will be added as they are graded. Related: clinic claims checker.